NASDAQ:ETNB 89bio (ETNB) Insider Trading & Ownership $14.40 -0.02 (-0.14%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$13.90▼$14.5050-Day Range$14.40▼$17.7852-Week Range$5.61▼$22.93Volume988,476 shsAverage Volume1.52 million shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/APrice Target$37.44 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media 89bio (NASDAQ:ETNB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$49.99 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.52 M Get ETNB Insider Trade Alerts Want to know when executives and insiders are buying or selling 89bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ETNB Insider Buying and Selling by Quarter 89bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/17/2023Kathleen LaporteDirectorSell12,500$18.80$235,000.00 6/5/2023Rohan PalekarCEOSell15,000$20.00$300,000.00 6/1/2023Edward Morrow Atkinson IIIDirectorSell6,250$17.91$111,937.50 5/9/2023Quoc Le-NguyenInsiderSell13,683$18.11$247,799.13 4/4/2023Ryan MartinsCFOSell8,721$14.95$130,378.95 3/30/2023Michael R HaydenDirectorBuy6,250$3.62$22,625.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/28/2023Michael R HaydenDirectorBuy61,538$16.15$993,838.70 3/24/2023Ra Capital Management, L.P.DirectorBuy2,461,538$16.25$39,999,992.50 3/23/2023Rohan PalekarCEOSell15,000$16.00$240,000.00 3/23/2023Ryan MartinsCFOSell5,000$16.11$80,550.00 2/21/2023Ryan MartinsCFOSell2,540$13.89$35,280.60 2/8/2023Ryan MartinsCFOSell1,480$14.41$21,326.80 2/3/2023Ryan MartinsCFOSell3,592$13.04$46,839.68 1/3/2023Ryan MartinsCFOSell5,947$12.51$74,396.97 10/18/2022Ra Capital Management, L.P.DirectorBuy1,172,741$7.65$8,971,468.65 (Data available from 1/1/2013 forward) ETNB Insider Trading Activity - Frequently Asked Questions Who is on 89bio's Insider Roster? The list of insiders at 89bio includes Edward Morrow Atkinson III, Gregory Grunberg, Kathleen Laporte, Michael R Hayden, Orbimed Advisors Llc, Quoc Le-Nguyen, Ra Capital Management, L.P., Ram Waisbourd, Rohan Palekar, and Ryan Martins. Learn more on insiders at ETNB. What percentage of 89bio stock is owned by insiders? 4.40% of 89bio stock is owned by insiders. Learn more on ETNB's insider holdings. Which 89bio insiders have been buying company stock? The following insiders have purchased ETNB shares in the last 24 months: Michael R Hayden ($1,016,463.70), Ra Capital Management, L.P. ($58,971,456.15), and Rohan Palekar ($37,500.00). How much insider buying is happening at 89bio? Insiders have purchased a total of 6,523,967 ETNB shares in the last 24 months for a total of $60,025,419.85 bought. Which 89bio insiders have been selling company stock? The following insiders have sold ETNB shares in the last 24 months: Edward Morrow Atkinson III ($111,937.50), Kathleen Laporte ($235,000.00), Orbimed Advisors Llc ($412,364.40), Quoc Le-Nguyen ($247,799.13), Ram Waisbourd ($358,120.00), Rohan Palekar ($540,000.00), and Ryan Martins ($388,773.00). How much insider selling is happening at 89bio? Insiders have sold a total of 166,804 89bio shares in the last 24 months for a total of $2,293,994.03 sold. More Insider Trading Tools from MarketBeat Related Companies: ANI Pharmaceuticals Insider Trades Viking Therapeutics Insider Trades Aurinia Pharmaceuticals Insider Trades Kiniksa Pharmaceuticals Insider Trades Mirum Pharmaceuticals Insider Trades Biohaven Insider Trades OPKO Health Insider Trades Xencor Insider Trades Merus Insider Trades Geron Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:ETNB) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.